- Home
- CGON vs CMBT Comparison
CGON vs CMBT Comparison
Compare CGON & CMBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- CMBT
- Stock Information
- Founded
- CGON 2010
- CMBT 1989
- Country
- CGON United States
- CMBT Belgium
- Employees
- CGON N/A
- CMBT N/A
- Industry
- CGON
- CMBT
- Sector
- CGON
- CMBT
- Exchange
- CGON NYSE
- CMBT NYSE
- Market Cap
- CGON 2.4B
- CMBT 2.5B
- IPO Year
- CGON 2024
- CMBT N/A
- Fundamental
- Price
- CGON $28.45
- CMBT $9.42
- Analyst Decision
- CGON Strong Buy
- CMBT
- Analyst Count
- CGON 8
- CMBT 0
- Target Price
- CGON $63.88
- CMBT N/A
- AVG Volume (30 Days)
- CGON 819.4K
- CMBT 146.3K
- Earning Date
- CGON 02-02-2025
- CMBT 01-30-2025
- Dividend Yield
- CGON N/A
- CMBT 56.80%
- EPS Growth
- CGON N/A
- CMBT 75.60
- EPS
- CGON N/A
- CMBT 5.97
- Revenue
- CGON $684,000.00
- CMBT $982,850,000.00
- Revenue This Year
- CGON $165.75
- CMBT N/A
- Revenue Next Year
- CGON $47.04
- CMBT $18.94
- P/E Ratio
- CGON N/A
- CMBT $1.55
- Revenue Growth
- CGON 258.12
- CMBT N/A
- 52 Week Low
- CGON $25.77
- CMBT $8.59
- 52 Week High
- CGON $50.23
- CMBT $21.26
- Technical
- Relative Strength Index (RSI)
- CGON 31.50
- CMBT 27.32
- Support Level
- CGON $27.58
- CMBT $8.59
- Resistance Level
- CGON $36.73
- CMBT $11.36
- Average True Range (ATR)
- CGON 2.01
- CMBT 0.42
- MACD
- CGON -0.52
- CMBT -0.03
- Stochastic Oscillator
- CGON 9.51
- CMBT 26.97
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About CMBT EURONAV
CMB.Tech NV owns and operates a fleet of vessels for international maritime shipping and storage of crude oil and petroleum products. It generate a large parts of their revenue from voyage charters, including vessels in pools that predominantly perform voyage charters. The company organises itself into two segments: tankers and floating storage and offloading activities, or FSO. The tankers segment, which generates the majority of revenue, operates crude oil tankers on international markets. The FSO segment conducts floating production, floating storage, and offloading operations for crude oil and petroleum products.